Drugs / Egg white solid powder
Egg white solid powder
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00461097 | May 2007 → Dec 2010 | food allergy | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | Met primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Egg white solid powder | “Egg white solid powder” NCT00461097 ↗ |
| Known as | egg white solid | “Subjects ingest egg white solid (EWS) on Visit 1 (initial day dose escalation up to 50 mg), followed by a build-up phase (escalating daily egg doses every 2 wks, achieving a...” NCT00461097 ↗ |
| Known as | EWS | “Subjects ingest egg white solid (EWS) on Visit 1 (initial day dose escalation up to 50 mg), followed by a build-up phase (escalating daily egg doses every 2 wks, achieving a...” NCT00461097 ↗ |
| Route | Oral | “received oral immunotherapy” PMID 22808958 ↗ Jul 2012 |